Oriola

0.913EUR -1.19 %
7,447 investors are following this company

Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.

P/E (23e)
18.74
EV/EBIT (adj.) (23e)
8.64
P/B (23e)
0.74
Dividend yield-% (23e)
6.57 %
Target price
1.05 EUR
Recommendation
Accumulate
Updated
29.8.2023
NASDAQ Helsinki
OKDBV
Daily low / high price
0.91 / 0.931 EUR
Market cap
174.14M EUR
Turnover
205.1K EUR
Volume
224K
Risk and recommendation
HighRiskLow
SellRecommendationBuy

Analyst

Rauli Juva
Rauli Juva
Analyst

Financial calendar

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Mariatorp Oy14.4 %13.4 %
Wipunen varainhallinta oy5.0 %4.9 %
Premium
Not activated

This content is for our Premium customers only.

Insider Transactions

InsiderDateTotal value
Anne Kariniemi2022-03-042,099.7439EUR
Katarina Gabrielson2022-03-043,039.9867EUR
Premium
Not activated

This content is for our Premium customers only.

Income statement

20192020202120222023e2024e2025e2026e
Revenue1,721.261,800.761,882.401,841.401,486.501,531.101,577.031,624.34
growth-%10.89 %4.62 %4.53 %-2.18 %-19.27 %3.00 %3.00 %3.00 %
EBITDA60.6163.0865.4068.6030.9034.9237.7440.18
EBIT (adj.)20.4520.9526.3034.5016.7020.0023.0025.00
EBIT15.3120.3820.5040.2016.5020.0023.0025.00
Profit before taxes10.1314.3514.7035.4010.8319.0923.2826.60
Net income7.9811.2811.3027.408.6316.4720.1523.18
EPS (adj.)0.070.070.090.120.050.090.110.13
growth-%-48.85 %-9.64 %44.36 %26.90 %-59.30 %86.43 %22.35 %15.02 %
Dividend0.090.030.040.060.060.060.070.08
Dividend ratio204.54 %48.24 %64.19 %39.71 %126.02 %66.06 %63.00 %65.00 %

Profitability and return on capital

20192020202120222023e2024e2025e2026e
EBITDA-%3.52 %3.50 %3.47 %3.73 %2.08 %2.28 %2.39 %2.47 %
EBIT-% (adj.)1.19 %1.16 %1.40 %1.87 %1.12 %1.31 %1.46 %1.54 %
EBIT-%0.89 %1.13 %1.09 %2.18 %1.11 %1.31 %1.46 %1.54 %
ROE4.76 %6.90 %5.85 %12.38 %3.84 %7.28 %8.62 %9.52 %
ROI4.68 %5.02 %4.60 %10.19 %5.16 %7.79 %8.96 %9.78 %

Valuation

20192020202120222023e2024e2025e2026e
Share price (EUR)2.031.902.011.740.910.910.910.91
Shares181.38181.31181.35181.34181.34181.34181.34181.34
Market cap367.30344.86363.60315.53165.56165.56165.56165.56
Enterprise value486.90471.93464.37291.83144.23139.17131.86123.52
EV/S0.280.260.250.160.100.090.080.08
EV/EBITDA8.037.487.104.254.673.983.493.07
EV/EBIT (adj.)23.8122.5317.668.468.646.965.734.94
EV/EBIT31.8023.1622.657.268.746.965.734.94
P/E (adj.)28.0129.1121.2614.5418.7410.058.227.14
P/E46.0530.5932.1711.5119.1810.058.227.14
P/B2.342.031.681.400.740.720.690.67
P/S0.210.190.190.170.110.110.100.10
Dividend yield4.44 %1.58 %2.00 %3.45 %6.57 %6.57 %7.67 %9.10 %
Equity ratio15.25 %14.55 %19.83 %23.49 %24.90 %25.09 %25.62 %26.29 %
Gearing ratio76.08 %74.92 %46.48 %-10.50 %-9.55 %-11.52 %-14.14 %-16.90 %

Quarter data

Q3/22Q4/222022Q1/23Q2/23Q3/23eQ4/23e2023eQ1/24e
Revenue480.90374.201,841.40354.70383.70370.16377.941,486.50
EBITDA23.105.0068.607.106.808.108.9030.90
EBIT19.20-9.0040.203.503.204.505.3016.50
Profit before taxes18.40-9.8035.401.501.503.504.3010.83
Net income14.60-8.1027.401.101.172.843.468.63